We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

181 hedge funds and large institutions have $3.05B invested in Intercept Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 47

8% more funds holding

Funds holding: 167 → 181 (+14)

2% less capital invested

Capital invested by funds: $3.12B → $3.05B (-$62.2M)

39% less call options, than puts

Call options by funds: $109M | Put options by funds: $179M

Holders
181
Holders Change
+14
Holders Change %
+8.38%
% of All Funds
5.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
37
Increased
81
Reduced
47
Closed
21
Calls
$109M
Puts
$179M
Net Calls
-$69.4M
Net Calls Change
+$62.5M

Top Buyers

Rank Fund Capital Flow
1
CG
Carmignac Gestion
France
+$84.1M
2
Millennium Management
Millennium Management
New York
+$74.9M
3
CCI
Columbus Circle Investors
+$39.2M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$38.3M
5
Franklin Resources
Franklin Resources
California
+$35.4M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$298M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$91.6M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$49.2M
4
O
OrbiMed
New York
-$43.7M
5
Norges Bank
Norges Bank
Norway
-$31.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
76
First Trust Advisors
Illinois
$2.67M +$2.88M +11,285 New
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$2.56M +$1.05M +4,101 +61%
LI
78
LMCG Investments
Massachusetts
$2.54M +$1.11M +4,360 +68%
Barclays
79
Barclays
United Kingdom
$2.48M +$2.55M +10,015 +2,086%
Principal Financial Group
80
Principal Financial Group
Iowa
$2.44M – – –
CSS
81
Cubist Systematic Strategies
Connecticut
$2.39M -$793K -3,109 -24%
Axa
82
Axa
France
$2.37M +$2.55M +10,000 New
CCMU
83
Cheyne Capital Management (UK)
United Kingdom
$2.34M +$2.52M +9,876 New
State of Wisconsin Investment Board
84
State of Wisconsin Investment Board
Wisconsin
$2.18M +$2.35M +9,200 New
Wells Fargo
85
Wells Fargo
California
$2.14M -$2.98M -11,673 -56%
U
86
UBS
Switzerland
$2.09M -$2.47M -9,677 -52%
HI
87
HBK Investments
Texas
$2.01M -$5M -19,600 -70%
EA
88
Emerald Advisers
Pennsylvania
$1.94M -$4.32M -16,936 -67%
TA
89
Teachers Advisors
New York
$1.91M +$53K +208 +3%
JG
90
Jefferies Group
New York
$1.88M +$1.53M +6,015 +309%
PAM
91
Paradigm Asset Management
New York
$1.82M +$1.96M +7,700 New
AllianceBernstein
92
AllianceBernstein
Tennessee
$1.8M -$14.4M -56,629 -88%
M&T Bank
93
M&T Bank
New York
$1.78M +$1.91M +7,504 New
PA
94
Profund Advisors
Maryland
$1.7M +$1.83M +7,179 New
RIM
95
RS Investment Management
California
$1.66M +$969K +3,802 +118%
Dimensional Fund Advisors
96
Dimensional Fund Advisors
Texas
$1.59M +$1.1M +4,324 +183%
NI
97
Numeric Investors
Massachusetts
$1.56M +$1.04M +4,080 +162%
VOYA Investment Management
98
VOYA Investment Management
Georgia
$1.49M -$12.7K -50 -0.8%
KCM
99
Kingdon Capital Management
New York
$1.42M +$1.53M +6,000 New
Calamos Advisors
100
Calamos Advisors
Illinois
$1.39M +$1.5M +5,871 New
2 3
4
5 6

ICPT Hedge Fund Activity: Q3 2014 in Review

181 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q3 2014, worth a combined $3.05B — down 2% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ICPT positions and 21 closed out — a net gain of 16 holders — while 81 added to existing stakes and 47 trimmed.

The largest buyer was Carmignac Gestion, adding an estimated $84.1M. The largest seller was Jennison Associates, cutting an estimated $298M.

  • 181 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q3 2014, up from 167 in Q2 2014.
  • Funds reported $3.05B of Intercept Pharmaceuticals, Inc. stock for Q3 2014, down 2% quarter-over-quarter.
  • 37 funds opened new Intercept Pharmaceuticals, Inc. positions in Q3 2014 and 21 closed out, a net change of +16 holders.
  • The largest Intercept Pharmaceuticals, Inc. buyer in Q3 2014 was Carmignac Gestion, an estimated $84.1M added.
  • The largest Intercept Pharmaceuticals, Inc. seller in Q3 2014 was Jennison Associates, an estimated $298M sold.

Based on aggregated 13F filings for Q3 2014.